Riverview Capital Advisers’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $838K | Sell |
11,991
-966
| -7% | -$67.5K | 0.24% | 62 |
|
|
2025
Q1 | $952K | Hold |
12,957
| – | – | 0.3% | 58 |
|
|
2024
Q4 | $849K | Hold |
12,957
| – | – | 0.26% | 59 |
|
|
2024
Q3 | $1.01M | Hold |
12,957
| – | – | 0.31% | 52 |
|
|
2024
Q2 | $1.01M | Hold |
12,957
| – | – | 0.34% | 53 |
|
|
2024
Q1 | $878K | Hold |
12,957
| – | – | 0.3% | 53 |
|
|
2023
Q4 | $873K | Buy |
12,957
+37
| +0.3% | +$2.49K | 0.33% | 50 |
|
|
2023
Q3 | $875K | Hold |
12,920
| – | – | 0.39% | 57 |
|
|
2023
Q2 | $925K | Hold |
12,920
| – | – | 0.41% | 53 |
|
|
2023
Q1 | $897K | Hold |
12,920
| – | – | 0.39% | 57 |
|
|
2022
Q4 | $876K | Hold |
12,920
| – | – | 0.47% | 48 |
|
|
2022
Q3 | $709K | Hold |
12,920
| – | – | 0.44% | 53 |
|
|
2022
Q2 | $854K | Hold |
12,920
| – | – | 0.47% | 51 |
|
|
2022
Q1 | $857K | Hold |
12,920
| – | – | 0.39% | 54 |
|
|
2021
Q4 | $753K | Buy |
+12,920
| New | +$753K | 0.33% | 57 |
|